share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4：持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  10/12 02:04

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) has reported a significant transaction involving its Chairman & CEO, Albert Bourla. According to the announcement, the transaction took place on October 10, 2024. However, the details regarding the number of shares, the nature of the shares, the transaction price, and the total value of the shares involved in the transaction were not disclosed. The report also did not specify the number of shares held by Bourla after the transaction. This information is crucial for investors to understand the potential impact of the transaction on their holdings and the market's perception of Pfizer's stock.
Pfizer Inc. (PFE) has reported a significant transaction involving its Chairman & CEO, Albert Bourla. According to the announcement, the transaction took place on October 10, 2024. However, the details regarding the number of shares, the nature of the shares, the transaction price, and the total value of the shares involved in the transaction were not disclosed. The report also did not specify the number of shares held by Bourla after the transaction. This information is crucial for investors to understand the potential impact of the transaction on their holdings and the market's perception of Pfizer's stock.
輝瑞公司（PFE）報告了一筆涉及其董事長兼首席執行官阿爾伯特·伯拉的重大交易。根據公告，交易發生在2024年10月10日。然而，關於交易涉及的股票數量、股票性質、交易價格以及交易涉及的股票總價值的詳細信息並未披露。報告還未指明伯拉在交易後持有的股份數量。這些信息對投資者來說至關重要，以了解交易可能對其持股和市場對輝瑞股票看法的潛在影響。
輝瑞公司（PFE）報告了一筆涉及其董事長兼首席執行官阿爾伯特·伯拉的重大交易。根據公告，交易發生在2024年10月10日。然而，關於交易涉及的股票數量、股票性質、交易價格以及交易涉及的股票總價值的詳細信息並未披露。報告還未指明伯拉在交易後持有的股份數量。這些信息對投資者來說至關重要，以了解交易可能對其持股和市場對輝瑞股票看法的潛在影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間